{"id":"NCT00829296","sponsor":"University of Chicago","briefTitle":"Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the Arteries","officialTitle":"The Effects of Nebivolol on Aortic Impedance Parameters in Type 2 Diabetics","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2009-01","primaryCompletion":"2012-04","completion":"2013-04","firstPosted":"2009-01-27","resultsPosted":"2014-11-05","lastUpdate":"2016-02-05"},"enrollment":70,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Hypertension","Diabetes"],"interventions":[{"type":"DRUG","name":"nebivolol","otherNames":["bystolic"]},{"type":"DRUG","name":"Metoprolol","otherNames":["lopressor"]}],"arms":[{"label":"nebivolol","type":"EXPERIMENTAL"},{"label":"Metoprolol","type":"ACTIVE_COMPARATOR"}],"summary":"The study is being done to see if a drug shown to lower the risk of heart failure is also effective in reducing the stiffness of the arteries.","primaryOutcome":{"measure":"Change in Central Systolic Blood Pressure (SBP)","timeFrame":"Baseline and 26 Weeks","effectByArm":[{"arm":"Nebivolol","deltaMin":125.3,"sd":8},{"arm":"Metoprolol","deltaMin":127.8,"sd":8.8}],"pValues":[]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":7},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":34},"commonTop":["Fatigue","Diarrhea","Dizziness"]}}